Free Trial

INVO Fertility (IVF) Competitors

$0.86 -0.01 (-1.31%)
As of 07/3/2025 12:54 PM Eastern

IVF vs. POAI, LFWD, TNON, STRR, LUCY, AMIX, BLAC, QNRX, ICU, and CHEK

Should you be buying INVO Fertility stock or one of its competitors? The main competitors of INVO Fertility include Predictive Oncology (POAI), Lifeward (LFWD), Tenon Medical (TNON), Star Equity (STRR), Innovative Eyewear (LUCY), Autonomix Medical (AMIX), Bellevue Life Sciences Acquisition (BLAC), Quoin Pharmaceuticals (QNRX), SeaStar Medical (ICU), and Check-Cap (CHEK). These companies are all part of the "medical equipment" industry.

INVO Fertility vs. Its Competitors

INVO Fertility (NASDAQ:IVF) and Predictive Oncology (NASDAQ:POAI) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, earnings, dividends, valuation, institutional ownership, profitability and risk.

12.0% of INVO Fertility shares are held by institutional investors. Comparatively, 9.0% of Predictive Oncology shares are held by institutional investors. 0.6% of INVO Fertility shares are held by insiders. Comparatively, 3.4% of Predictive Oncology shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

INVO Fertility has a beta of 2.04, suggesting that its share price is 104% more volatile than the S&P 500. Comparatively, Predictive Oncology has a beta of 1.17, suggesting that its share price is 17% more volatile than the S&P 500.

INVO Fertility has a net margin of -377.73% compared to Predictive Oncology's net margin of -629.68%. INVO Fertility's return on equity of 0.00% beat Predictive Oncology's return on equity.

Company Net Margins Return on Equity Return on Assets
INVO Fertility-377.73% N/A -88.18%
Predictive Oncology -629.68%-671.29%-132.49%

INVO Fertility has higher revenue and earnings than Predictive Oncology. Predictive Oncology is trading at a lower price-to-earnings ratio than INVO Fertility, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
INVO Fertility$6.53M0.29-$9.10M-$34.06-0.03
Predictive Oncology$1.62M4.70-$12.66M-$3.05-0.28

Predictive Oncology has a consensus price target of $3.00, suggesting a potential upside of 252.11%. Given Predictive Oncology's stronger consensus rating and higher probable upside, analysts plainly believe Predictive Oncology is more favorable than INVO Fertility.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
INVO Fertility
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Predictive Oncology
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

In the previous week, INVO Fertility and INVO Fertility both had 1 articles in the media. Predictive Oncology's average media sentiment score of 0.44 beat INVO Fertility's score of 0.00 indicating that Predictive Oncology is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
INVO Fertility
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Predictive Oncology
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

INVO Fertility beats Predictive Oncology on 8 of the 14 factors compared between the two stocks.

Get INVO Fertility News Delivered to You Automatically

Sign up to receive the latest news and ratings for IVF and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IVF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IVF vs. The Competition

MetricINVO FertilityMedical Services IndustryMedical SectorNASDAQ Exchange
Market Cap$1.87M$7.31B$5.54B$9.05B
Dividend YieldN/A2.78%5.24%4.02%
P/E Ratio-0.0327.9427.4320.23
Price / Sales0.2932.39422.11118.64
Price / CashN/A22.0136.8958.07
Price / Book-0.036.698.045.67
Net Income-$9.10M$233.06M$3.18B$249.13M
7 Day Performance-5.86%3.33%2.89%3.28%
1 Month Performance-42.01%3.72%3.70%5.56%
1 Year PerformanceN/A37.40%36.15%21.12%

INVO Fertility Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IVF
INVO Fertility
N/A$0.86
-1.3%
N/AN/A$1.87M$6.53M-0.0310
POAI
Predictive Oncology
2.156 of 5 stars
$0.83
+0.0%
$3.00
+261.4%
-15.6%$7.41M$1.62M-0.2730News Coverage
Positive News
LFWD
Lifeward
2.8685 of 5 stars
$0.64
-3.8%
$9.00
+1,295.8%
-81.9%$7.38M$25.66M-0.2160Gap Up
High Trading Volume
TNON
Tenon Medical
1.4382 of 5 stars
$0.98
+2.9%
$4.67
+377.5%
+29.0%$7.21M$3.28M-0.048News Coverage
Positive News
Gap Down
STRR
Star Equity
3.5977 of 5 stars
$2.00
-1.0%
$5.00
+150.0%
-50.9%$6.48M$53.36M-0.58460Positive News
LUCY
Innovative Eyewear
0.4985 of 5 stars
$2.12
+1.9%
N/A-77.0%$6.44M$1.64M-0.539Gap Down
AMIX
Autonomix Medical
3.2885 of 5 stars
$1.57
-21.9%
$16.50
+951.0%
-89.0%$5.59MN/A-0.211Negative News
Gap Up
High Trading Volume
BLAC
Bellevue Life Sciences Acquisition
N/A$1.35
+8.0%
N/A-87.5%$5.46MN/A0.00N/AHigh Trading Volume
QNRX
Quoin Pharmaceuticals
0.5341 of 5 stars
$9.23
-0.4%
N/A-55.2%$5.45MN/A-0.194Gap Down
ICU
SeaStar Medical
1.2056 of 5 stars
$0.43
+5.1%
N/A-94.1%$4.54M$140K-0.122
CHEK
Check-Cap
0.4725 of 5 stars
$0.77
+0.7%
N/A-64.2%$4.48MN/A-0.2680News Coverage

Related Companies and Tools


This page (NASDAQ:IVF) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners